
Royal Sense (ROYAL) | Stock Overview & Key Data
Royal Sense Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹316.05 on December 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Royal Sense ROYAL | 1.10B Small-cap | -0.97% | -14.37% | -5.51% | -22.64% | -33.01% | 41.38% | 83.91% | 83.91% |
Entero Healthcare ENTERO | 51.95B Mid-cap | -1.13% | 5.00% | -4.26% | -7.68% | -10.23% | 4.72% | 12.11% | 12.11% |
Amwill Health Care AMWILL | 1.19B Small-cap | 0.12% | -11.19% | -28.20% | -36.19% | -36.19% | -39.53% | -39.53% | -39.53% |
NOVELIX NOVELIX | 543.27M Small-cap | 2.09% | -5.15% | 50.32% | 57.84% | 57.84% | 57.84% | 57.84% | 57.84% |
Trimurthi TRIMURTHI | 264.77M Small-cap | 2.09% | -5.15% | 50.32% | 65.68% | 73.91% | 111.27% | 425.00% | 1,128.07% |
Zenlabs Ethica ZENLABS | 214.64M Small-cap | -4.05% | -4.79% | 0.60% | -8.96% | -20.06% | -19.26% | -27.87% | 35.55% |
Ownership & Short Interest
Royal Sense Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Royal Sense would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ROYAL's 52-week high and low?
- In the last 52 weeks, Royal Sense reached a high of ₹316.05 (on January 3, 2025) and a low of ₹133.00 (on August 14, 2024).
- What is the market cap and P/E ratio for ROYAL?
- Curious about Royal Sense's size and valuation? Its market capitalization stands at 1.10B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.33, and the forward P/E (looking ahead) is N/A.
- Does ROYAL pay dividends? If so, what's the yield?
- As for dividends, Royal Sense isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Royal Sense's main competitors or similar companies to consider before investing?
When looking at Royal Sense, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Entero Healthcare
ENTERO51.95B Healthcare Medical Distribution 4.72% 12.11% Amwill Health Care
AMWILL1.19B Healthcare Medical Distribution -39.53% -39.53% NOVELIX
NOVELIX543.27M Healthcare Medical Distribution 57.84% 57.84% Trimurthi
TRIMURTHI264.77M Healthcare Medical Distribution 111.27% 425.00% Zenlabs Ethica
ZENLABS214.64M Healthcare Medical Distribution -19.26% -27.87% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Royal Sense Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Royal Sense's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 27.55%, the Debt to Equity ratio from the most recent quarter is 11.74, and its Gross Profit Margin stands at 15.60%.
- What is the recent revenue and earnings growth for ROYAL?
- Looking at Royal Sense's growth, its revenue over the trailing twelve months (TTM) was INR617M. Compared to the same quarter last year (YoY), quarterly revenue grew by 713.10%, and quarterly earnings saw a YoY growth of 792.70%.
- How much of ROYAL stock is held by insiders and institutions?
- Wondering who owns Royal Sense stock? Company insiders (like executives and directors) hold about 64.62% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.